APA (7th ed.) Citation

Maggi, P., Ricci, E. D., Cicalini, S., Pellicanò, G. F., Celesia, B. M., Vichi, F., . . . Di Biagio, A. (2023). Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens. BMC Infectious Diseases, 23(1), 1. https://doi.org/10.1186/s12879-023-08191-2

Chicago Style (17th ed.) Citation

Maggi, Paolo, et al. "Lipids and Transaminase Elevations in ARV-experienced PLWH Switching to a Doravirine-based Regimen from Rilpivirine or Other Regimens." BMC Infectious Diseases 23, no. 1 (2023): 1. https://doi.org/10.1186/s12879-023-08191-2.

MLA (9th ed.) Citation

Maggi, Paolo, et al. "Lipids and Transaminase Elevations in ARV-experienced PLWH Switching to a Doravirine-based Regimen from Rilpivirine or Other Regimens." BMC Infectious Diseases, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12879-023-08191-2.